These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5736827)

  • 21. Method for removing leukocytes and thrombocytes from preserved blood and packed red cells.
    Nikolov C; Milev A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):137-41. PubMed ID: 6157617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The supply of blood and blood components for the clinician].
    Arndt-Hanser A; Schütt KH
    Klin Anasthesiol Intensivther; 1980; 21():80-93. PubMed ID: 7453082
    [No Abstract]   [Full Text] [Related]  

  • 23. Formation of debris in stored human blood.
    Risberg B
    Haematologia (Budap); 1981; 14(1):57-61. PubMed ID: 7250818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Search for methods of prolonged preservation of thrombocytes in a frozen state].
    Skopina SB; Koroliuk KI
    Probl Gematol Pereliv Krovi; 1966 Sep; 11(9):30-5. PubMed ID: 5996618
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
    Posch U; Kokelj M; Kostner GM; Lanzer G
    Beitr Infusionsther Transfusionsmed; 1994; 32():78-80. PubMed ID: 9480162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The spectrum of cell volumes: erythrocytes, leukocytes, blood plateletes. Distribution analysis with a multichannel pulse analyzer].
    Le Go R; Le Go A; Crouillère R
    Nouv Rev Fr Hematol; 1970; 10(6):709-25. PubMed ID: 4251073
    [No Abstract]   [Full Text] [Related]  

  • 27. [Appearance of iso-antibodies against the blood platelets, leukocytes and erythrocytes after blood transfusion].
    WALEWSKA I; GULMANTOWICZ A; KACPERSKA E; FRANKOWSKA K; CHOJNACKA I; KALINSKA J; SENDYSN
    Pol Tyg Lek; 1961 Aug; 16():1262-7. PubMed ID: 14004546
    [No Abstract]   [Full Text] [Related]  

  • 28. [Available method of rapid separation of leukocytic and thrombocytic mass from glucosetreated and citrated blood for transfusion].
    ARLOZOROV EG
    Probl Gematol Pereliv Krovi; 1957; 2(4):23-6. PubMed ID: 13484914
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fresh blood or its components for a directed transfusion therapy].
    Ehrich CC
    Anaesthesist; 1973 Jun; 22(6):274-5. PubMed ID: 4725652
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitative assessment of platelet morphology by light scattering: a potential method for the evaluation of platelets for transfusion.
    Fratantoni JC; Poindexter BJ; Bonner RF
    J Lab Clin Med; 1984 Apr; 103(4):620-31. PubMed ID: 6699477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of low-molecular polyvinylpyrrolidone as a protective medium for preservation and long-term storage of leukocytes by the deep-freeze method].
    Lavrik SS; Kogut GI; Afanas'eva EIu
    Vrach Delo; 1971 Dec; 12():80-3. PubMed ID: 5137879
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of thrombocyte concentrates from buffy coats after 3 and 16 hours of storage].
    Häberle H; Schulzki T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():73-7. PubMed ID: 9480161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further evaluation of CPD.
    Kevy SV
    Vox Sang; 1967 Jul; 13(1):114-8. PubMed ID: 6035807
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood preservation workshop: new and emerging trends in research and clinical practice.
    Holovati JL; Hannon JL; Gyongyossy-Issa MI; Acker JP
    Transfus Med Rev; 2009 Jan; 23(1):25-41. PubMed ID: 19056032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Serebruany V; Sabaeva E; Booze C; Atar OD; Eisert C; Hanley D;
    Thromb Haemost; 2009 Sep; 102(3):538-43. PubMed ID: 19718475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolation of marked elements of blood. (Application to a sample of 10 ml of human blood)].
    Pinot C; Kamoun P; Jérome H
    Ann Biol Clin (Paris); 1970; 28(1):85-8. PubMed ID: 5421253
    [No Abstract]   [Full Text] [Related]  

  • 37. Storage times of whole blood and of buffy coat determine leucocyte degradation in platelet concentrates.
    Karger R; Kretschmer V
    Vox Sang; 2005 Oct; 89(3):170; author reply 171. PubMed ID: 16146511
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [SURVIVAL OF LEUKOCYTES AND PLATELETS IN WHOLE BLOOD STORED AT +4 DEGREES C].
    GINESTE J; FOREST M; MAUPIN B
    Transfusion (Paris); 1964; 7():225-35. PubMed ID: 14212676
    [No Abstract]   [Full Text] [Related]  

  • 40. [Numerical and morphological changes of the leukocytes and platelets in stabilized and preserved blood].
    GALVE BRUNENGO C
    Med Cir Guerra; 1959; 21():691-700. PubMed ID: 13826210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.